ZM323881

Founded in 2016 and based in Fengxian District, Shanghai, Shanghai Rlavie Technology Co.,ltd (rlavie.com) manufactures, exports and trades heterocyclic building blocks used in pharmaceutical discovery and synthesis. Its very extensive catalog centers on pyridazine, imidazo[1,2-b]pyridazine, triazolopyridazine and related pyrimidine, pyrazole and tetralone/indanone/benzofuranone scaffolds used as advanced intermediates. The company offers CRO, CMO and CDMO contract services, ships under an unusually broad set of terms (FOB, CFR, CIF, EXW, FAS, CIP, FCA, CPT, DEQ, DDP, DDU, DAF, DES and express delivery) with L/C, L/L, T/T and D/P payment, and reports an even 50/50 split between export and domestic sales, selling across North and South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa.